Background
==========

Diabetic retinopathy (DR), a micro-vascular complication of diabetes, is a main cause of blindness in adults \[[@B1]\]. It is well established that DR is determined by both genetic and environmental factors. The longer duration of diabetes, poorer control of blood glucose and elevated blood pressure are the major risk factors in the development of DR. However, genetic factors also play important roles in the pathogenesis of DR \[[@B2]\]. It would be useful to identify molecular markers that may help to predict the development of DR at earlier stages of diabetes.

Vascular endothelial growth factor (VEGFA), an endothelial cellspecific mitogen, has been implicated as a major contributor to the development of DR \[[@B3]\]. VEGFA could induce the earliest changes in DR including leukostasis, blood-retinal barrier breakdown, and macular edema and neovascularization in progression of DR \[[@B4]\]. The *VEGFA* gene is located on chromosome 6p21.3 and consists of 8 exons. The genetic variants in the *VEGFA* gene are suggested to influence levels of VEGFA protein expression. To date, many studies have investigated the associations between polymorphisms in the *VEGFA* gene and DR. -634G/C (+405G/C or rs2010963) polymorphism in the 5′-untranslated region and-2578C/A (−2549I/D (in high linkage disequilibrium with -2578C/A) or rs699947) polymorphism in the promoter region of the *VEGFA* gene are most frequently investigated. However, the results have been inconsistent \[[@B5]-[@B16]\]. To date, three relevant meta-analyses \[[@B17]-[@B19]\] have published. However, only two studies for rs699947 polymorphism and five studies for rs2010963 were included in the meta-analysis by Abhary et al. \[[@B17]\]. Only 6 studies for rs2010963 were included in the meta-analysis by Zhao et al. \[[@B18]\]. Although Qiu et al. \[[@B19]\] found the positive association between rs2010963 polymorphism and DR, it should be noted that the association was only marginally significant as *p* value under allelic model and recessive model was 0.03. Most importantly, the recent meta-analysis by Qiu et al. \[[@B19]\] omitted two studies \[[@B7],[@B16]\] and included one study \[[@B20]\] where the genotype frequency of rs2010963 polymorphism was not in Hardy-Weinberg Equilibrium (HWE) in controls. Thus, the findings from the meta-analysis by Qiu et al. \[[@B19]\] were inaccurate. Most recently, a number of additional new articles have been published. Therefore, in this study, we performed an updated meta-analysis with 8 studies for rs699947 polymorphism and 10 studies for rs2010963 to further clarify the associations.

Methods
=======

Literature and search strategy
------------------------------

We searched PubMed, EMBASE, Web of Science and Google Scholar literature databases. The search strategy to identify all possible studies involved the use of the following key words: (the vascular endothelial growth factor OR *VEGFA* OR *VEGF*) and (variant OR variation OR polymorphism OR single nucleotide polymorphism OR SNP) and (diabetic retinopathy OR DR OR PDR). All related studies published in English language were included. The reference lists of retrieved articles were hand-searched. If more than one article were published using the same case series, only the study with the latest data was included. The literature search was updated on July 20, 2013.

Inclusion criteria and data extraction
--------------------------------------

The studies included in the meta-analysis met all the following inclusion criteria: (1) evaluated the association of *VEGFA* polymorphism (rs699947 or rs2010963) with DR; (2) used case--control or cohort design; and (3) provided sufficient data for calculation of odds ratio (OR) with 95% confidence interval (CI). The following information was extracted from each study: (1) name of the first author; (2) year of publication; (3) origin of country; (4) sample sizes of cases and controls; (5) genotype distributions of cases and controls; and (6) whether the variant was in HWE in controls. Two authors independently searched articles, assessed the articles for compliance with the inclusion/exclusion criteria, resolved disagreements and reached a consistent decision.

Statistical analysis
--------------------

The association of *VEGFA* polymorphism with DR was estimated by calculating pooled ORs and 95% CIs under a co-dominant, a dominant, and a recessive model, respectively. The significance of pooled OR was determined by Z test (*p* \< 0.05 was considered statistically significant). Q test was performed to evaluate the between-study heterogeneity. A random- (DerSimonian-Laird method \[[@B21]\] or fixed- (Mantel--Haenszel method) \[[@B22]\] effects model was used to calculate pooled OR in the presence (*p* ≤ 0.10) or absence (*p* \> 0.10) of heterogeneity, respectively. Subgroup analyses by ethnicity and type of DR were performed. Sensitivity analysis was performed after excluding one study at a time to test the stability of the result. Begg's funnel plot, a scatter plot of effect against a measure of study size, was generated as a visual aid to detect bias or systematic heterogeneity \[[@B23]\]. Publication bias was assessed by Egger's test \[[@B24]\] (*p* \< 0.05 was considered statistically significant). Data analysis was performed using STATA version 11 (StataCorp LP, College Station, TX, USA). In this meta-analysis, we used four genetic models for each of two polymorphisms, and Bonferroni method was used to correct for multiple comparisons (*p* = 0.05/8 = 0.00625).

Results
=======

Characteristics of the studies
------------------------------

The literature search identified a total of 162 potentially relevant papers. Of these, 133 papers were excluded because of obvious irrelevance by reading the titles and abstracts. In addition, two reviews \[[@B1],[@B25]\], three meta-analyses \[[@B17]-[@B19]\], and three article \[[@B26]-[@B28]\] which investigated the association of other polymorphism in the *VEGFA* gene with DR were excluded. Then, 21 papers met the primary inclusion criteria. However, one duplicated publication \[[@B29]\], four papers \[[@B30]-[@B33]\] which provided insufficient data for calculation of OR with 95% CI were further excluded. In addition, because the variant was not in HWE in controls, one article \[[@B15]\] for rs699947 polymorphism and three articles \[[@B20],[@B34],[@B35]\] for rs2010963 polymorphism were excluded. Additionally, since two studies were included in the article by Abhary et al. \[[@B8]\], they were considered as separate studies in the meta-analysis. At last, a total of 8 studies for rs699947 polymorphism and 10 studies for rs2010963 polymorphism were included in the final meta-analysis. A flow chart describing the study inclusion/exclusion is displayed as Figure  [1](#F1){ref-type="fig"}. The characteristics of the included studies are listed in Tables  [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}.
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###### 

**Characteristic of the studies included in the meta-analysis between rs699947 polymorphism in the*VEGFA*gene and diabetic retinopathy**

  **Study**                    **Country**   **Ethnicity**    **Sample size**   **Genotype frequency in cases**   **Genotype frequency in controls**   ***P***~**HWE**~                        
  ---------------------------- ------------- --------------- ----------------- --------------------------------- ------------------------------------ ------------------ ---- ----- ----- ---- -----
  Yang,2003 \[[@B5]\]          UK            European               64                        66                                  12                          31          21   13    38    15   Yes
  Awata,2005 \[[@B6]\]         Japan         East Asian             175                       203                                 95                          70          10   93    91    19   Yes
  Buraczynska,2007 \[[@B7]\]   Poland        European               195                       91                                  29                          80          86   29    43    19   Yes
  Abhary,2009 \[[@B8]\]        Australia     European               75                        93                                  17                          35          23   26    43    24   Yes
  Abhary,2009 \[[@B8]\]        Australia     European               136                       181                                 31                          74          31   45    91    45   Yes
  Nakamura,2009 \[[@B9]\]      Japan         East Asian             177                       292                                 85                          70          22   163   107   22   Yes
  Chun,2010 \[[@B10]\]         Korea         East Asian             253                       134                                123                         115          15   92    36    6    Yes
  Yang,2011 \[[@B11]\]         China         East Asian             129                       138                                 66                          47          16   82    51    5    Yes

###### 

**Characteristic of the studies included in the meta-analysis between rs2010963 polymorphism in the*VEGFA*gene and diabetic retinopathy**

  **Study**                       **Country**   **Ethnicity**    **Sample size**   **Genotype frequency in cases**   **Genotype frequency in controls**   ***P***~**HWE**~                        
  ------------------------------- ------------- --------------- ----------------- --------------------------------- ------------------------------------ ------------------ ---- ----- ----- ---- -----
  Awata,2005 \[[@B6]\]            Japan         East Asian             175                       200                                 46                          91          38   75    95    30   Yes
  Buraczynska,2007 \[[@B7]\]      Poland        European               195                       91                                  88                          88          19   42    41    8    Yes
  Errera,2007 \[[@B12]\]          Brazil        European               167                       334                                 57                          73          37   139   155   40   Yes
  Petrovic,2008 \[[@B13]\]        Slovenia      European               206                       143                                 79                         103          24   61    67    15   Yes
  Uthra,2008 \[[@B14]\]           India         South Asian            120                       79                                  60                          51          9    44    29    6    Yes
  Nakamura,2009 \[[@B9]\]         Japan         East Asian             176                       289                                 63                          79          34   84    146   59   Yes
  Kangas-Kontio,2009 \[[@B15]\]   Finland       European               126                       96                                  74                          42          10   52    39    5    Yes
  Chun,2010 \[[@B10]\]            Korea         East Asian             253                       134                                 85                         125          43   43    69    22   Yes
  Feghhi,2011 \[[@B16]\]          Iran          European               119                       279                                 43                          49          27   63    139   77   Yes
  Yang,2011 \[[@B11]\]            China         East Asian             129                       137                                 36                          74          19   39    72    26   Yes

Meta-analysis results
---------------------

A total of 1204 cases and 1198 controls were identified for the association between rs699947 polymorphism and DR. The results indicated that rs699947 polymorphism was marginally associated with DR under a homogeneous co-dominant model (AA vs. CC: OR = 1.69, 95% CI = 1.03-2.77, *p* = 0.040, Figure  [2](#F2){ref-type="fig"}) and a dominant model (AA + AC vs. CC: OR = 1.38, 95% CI = 1.01-1.90, *p* = 0.040). Further subgroup analysis suggested that the effect size was only significant among European populations under a dominant model (AA + AC vs. CC: OR = 1.47, 95% CI = 1.07--2.02, *p* = 0.018), but not among East Asian populations under all genetic models (Table  [3](#T3){ref-type="table"}). Since only two studies for proliferative DR (PDR) and one study for nonproliferative DR (NPDR) were investigated, the subgroup analysis by type of DR were not performed.

![**Meta-analysis of the association between rs699947 polymorphism in the*VEGFA*gene and diabetic retinopathy under a homogeneous co-dominant model (AA vs. CC).**](1471-2415-13-56-2){#F2}

###### 

**Pooled ORs and 95% CIs of the association between rs699947 polymorphism in the*VEGFA*gene and diabetic retinopathy**

  **Contrasts**   **No. of studies (cases/controls)**   **Homogeneous co-dominant model**   **Heterogeneous co-dominant model**   **Dominant model**   **Recessive model**                                                                                                             
  --------------- ------------------------------------- ----------------------------------- ------------------------------------- -------------------- --------------------- ------ --------------- ------ ------- ------ --------------- ------ ------- ------ --------------- ------ -------
  All             8 (1204/1198)                         1.69                                1.03-2.77 ^R^                         66.3                 0.004                 1.27   0.96-1.69 ^R^   54.2   0.032   1.38   1.01-1.90 ^R^   67.1   0.003   1.49   0.99-2.24 ^R^   61.5   0.011
  Ethnicity                                                                                                                                                                                                                                                                             
  European        4 (470/431)                           1.79                                0.87-3.67 ^R^                         69.7                 0.020                 1.31   0.93-1.83 ^F^   0.0    0.565   1.47   1.07-2.02 ^F^   46.4   0.133   1.53   0.87-2.68 ^R^   68.6   0.023
  East Asian      4 (734/767)                           1.59                                0.71-3.57 ^R^                         71.7                 0.014                 1.26   0.79-2.02 ^R^   77.3   0.004   1.33   0.82-2.14 ^R^   80.3   0.002   1.46   0.72-2.96 ^R^   65.1   0.035

R, random-effect model; F, fixed-effect model.

A total of 1666 cases and 1782 controls were identified for the association between rs2010963 polymorphism and DR. The results showed that there was no significant association between this polymorphism and DR under all genetic models (Table  [4](#T4){ref-type="table"} and Figure  [3](#F3){ref-type="fig"}), even after stratified for ethnicity and type of DR.

###### 

**Pooled ORs and 95% CIs of the association between rs2010963 polymorphism in the*VEGFA*gene and diabetic retinopathy**

  **Contrasts**   **No. of studies (cases/controls)**   **Homogeneous co-dominant model**   **Heterogeneous co-dominant model**   **Dominant model**   **Recessive model**                                                                                                             
  --------------- ------------------------------------- ----------------------------------- ------------------------------------- -------------------- --------------------- ------ --------------- ------ ------- ------ --------------- ------ ------- ------ --------------- ------ -------
  All             10 (1666/1782)                        1.11                                0.80-1.56 ^R^                         55.6                 0.016                 0.98   0.80-1.20 ^R^   40.6   0.087   1.01   0.81-1.26 ^R^   54.4   0.020   1.13   0.93-1.37 ^F^   28.1   0.186
  Ethnicity                                                                                                                                                                                                                                                                             
  European        5 (813/943)                           1.17                                0.64-2.13 ^R^                         70.0                 0.010                 0.90   0.66-1.23 ^R^   49.5   0.094   0.95   0.67-1.35 ^R^   65.0   0.022   1.25   0.81-1.92 ^R^   50.6   0.088
  East Asian      4 (733/760)                           1.06                                0.67-1.69 ^R^                         55.4                 0.081                 1.02   0.73-1.44 ^F^   50.3   0.110   1.04   0.72-1.49 ^R^   60.9   0.053   1.05   0.80-1.38 ^F^   17.1   0.306
  South Asian     1 (120/79)                            1.10                                0.36-3.32                             \-                   \-                    1.29   0.71-2.35       \-     \-      1.26   0.71-2.22       \-     \-      0.99   0.34-2.89       \-     \-
  Type of DR                                                                                                                                                                                                                                                                            
  PDR             7 (924/1376)                          1.14                                0.71-1.83 ^R^                         68.0                 0.005                 0.91   0.75-1.10 ^F^   34.2   0.167   0.97   0.73-1.28 ^R^   56.9   0.030   1.22   0.86-1.74 ^R^   53.5   0.045
  NPDR            3 (267/331)                           1.74                                0.70-4.29 ^R^                         62.9                 0.067                 1.45   0.73-2.87 ^R^   70.5   0.034   1.50   0.74-3.03 ^R^   74.5   0.020   1.36   0.85-2.18 ^F^   0.0    0.492

R, random-effect model; F, fixed-effect model.

![**Meta-analysis of the association between rs2010963 polymorphism in the*VEGFA*gene and diabetic retinopathy under a homogeneous co-dominant model (CC vs. GG).**](1471-2415-13-56-3){#F3}

Source of heterogeneity
-----------------------

Since there was significant between-study heterogeneity for both rs699947 and rs2010963 polymorphisms, we performed a meta-regression analysis to explore source of heterogeneity. We introduced variables including publication year, ethnicity, sample size in cases and controls. However, these variables can not explain the source of heterogeneity. Then, we drew Galbraith figure to further explore the outliers. The pooled results after exclusion of these outliers are listed in Additional file [1](#S1){ref-type="supplementary-material"}: Table S1. The between-study heterogeneity for two polymorphisms disappeared, and non-significant association for rs2010963 polymorphism with DR remained (Additional file [1](#S1){ref-type="supplementary-material"}: Table S1). However, the association between rs699947 polymorphism and DR changed to be significant under homogeneous co-dominant model (OR = 1.64, 95% CI = 1.18-2.28, *p* = 0.003, Figure  [4](#F4){ref-type="fig"}), even after sensitivity analysis was performed and multiple comparison correction was applied.

![**Meta-analysis of the association between rs699947 polymorphism in the*VEGFA*gene and diabetic retinopathy after exclusion of outliers under a homogeneous co-dominant model (AA vs. CC).**](1471-2415-13-56-4){#F4}

Potential publication bias
--------------------------

Using the Egger's test, no publication bias was detected for the studies on rs699947 polymorphism and rs2010963 polymorphism under all genetic models (all *p* \> 0.05).

Discussion
==========

The present updated meta-analysis confirmed the significant association between rs699947 polymorphism and DR after exclusion of outliers, and rs2010963 polymorphism might be not associated with DR. In the subgroup analysis, although rs699947 polymorphism was marginally associated with DR among Europeans under a dominant model, it did not reach statistical significance after multiple comparison correction.

To date, a number of studies have investigated association between VEGFA gene variants and risk of DR. Awata et al. \[[@B6]\] first reported that rs2010963 polymorphism was significantly associated with DR in Japanese patients with type 2 diabetes. However, the following studies demonstrated inconsistent results. Another polymorphisms (i.e. rs699947) has also been investigated and the conflicting results were also reported. The discrepant findings might be due to differences in the statistical power, the recruitment of studied population, the type of DR, and the genetic and environmental backgrounds.

In the present meta-analysis, there was evidence of between-study heterogeneity for both rs699947 and rs2010963 polymorphisms. The meta-regression analysis was performed to explore source of heterogeneity. However, variables such as publication year, ethnicity, sample size in cases and controls can not account for the source heterogeneity. After exclusion of outliers, the heterogeneity for both rs699947 and rs2010963 polymorphisms was abolished. Interestingly, there was significant association between rs699947 polymorphism and DR under a homogeneous co-dominant model (OR = 1.64, 95% CI = 1.18-2.28, *p* = 0.003), even after multiple comparison correction was applied.

The mechanism between *VEGFA* gene and DR is currently unclear. DR is characterized by increased vascular permeability, tissue ischemia and neovascularization. VEGFA can stimulate angiogenesis and increases the permeability of the microvasculature \[[@B17]\]. It has been suggested that VEGFA protein expression is affected by genetic variant in the *VEGFA* gene. Compared with VEGFA levels in the vitreous of diabetic eyes without PDR, those in the vitreous of patients with PDR are significantly elevated \[[@B36]\]. In addition, VEGFA inhibition has been indicated to cause a marked reduction in retinal neovascularization and prevention of the blood--retinal barrier breakdown \[[@B4]\].

Several limitations should be noted. First, the present meta-analysis was based primarily on unadjusted ORs with 95% CIs and the confounding factors (e.g. age, sex, duration of diabetes and hypertension) were not controlled for. Second, the effects of gene--gene and gene--environment interactions were not addressed in this meta-analysis since the original publications did not provide the related data. Third, the results in the subgroups should be interpreted with caution because of limited sample size. Fourth, for rs699947 polymorphism, since majority of included studies did not report the association with type of DR, we are unable to perform the further analysis. Fifth, we only assessed two polymorphisms in the *VEGFA* gene, therefore, we can not rule out the possibility that other polymorphisms or haplotypes in this gene might be implicated in the development of DR.

Conclusions
===========

In conclusions, the results of our meta-analysis indicated that there was a significantly association between *VEGFA* rs699947 polymorphism and risk of DR after exclusion of outliers, whereas rs2010963 polymorphism might be not associated with risk of DR. Further well-designed large-scale studies with the consideration of gene--gene and gene--environment interactions should be conducted to investigate the association in future.
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